Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: Optom Vis Sci. 2022 Mar 1;99(3):213–227. doi: 10.1097/OPX.0000000000001867

Appendix Table A6.

Change in Ocular Deviation from Baseline by Treatment Group.

4 weeks 8 weeks
Binocular Treatment Continued Spectacles Binocular Treatment Continued Spectacles
N with Change/ N Eligible % N with Change/ N Eligible % N with Change/ N Eligible % N with Change/ N Eligible %
New strabismusa 7/88 8% 7/84 8% 6/86 7% 7/84 8%
Increased magnitude of strabismus by ≥10Δb 0/20 0% 2/17 12% 0/20 0% 2/17 12%
Strabismus at baseline no longer presentc 6/20 30% 6/17 35% 6/20 30% 4/17 24%
a

Barnard’s exact test was used to compare the proportion of participants with new strabismus at 4 weeks (P = .98) and at 8 weeks (P = .81) between the treatment groups.

b

Barnard’s exact test was used to compare the proportion of participants with strabismus magnitude that increased by ≥ 10Δ at 4 weeks (P = .15) and at 8 weeks (P = .15) between the treatment groups.

c

Barnard’s exact test was used to compare the proportion of participants with a strabismus at baseline that was no longer present at 4 weeks (P = .77) or at 8 weeks (P = .71) between the treatment groups.